• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

A case study investigating the efficacy of two treatments, botox and SaeboFlex in reduced hand function due to flexor spasticity
Purpose: Dynamic hand splints such as Saeboflex are a promising intervention for aiding functional use of a person's hand following a stroke. If spasticity is present it can be a major limiting factor in using a Saeboflex. The purpose of this case study is to report the use of a combination of Botulinum Toxin Type A (BtxA) to reduce spasticity, prior to initiating a repetitive training rehabilitation programme with a Saeboflex.
Source: Physiotherapy - January 1, 2019 Category: Physiotherapy Authors: J.A. Benson Tags: P087 Source Type: research

The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A.
Authors: Picelli A, Baricich A, Cisari C, Paolucci S, Smania N, Sandrini G Abstract The present national survey seeking to identify unmet needs in the management of spasticity with botulinum toxin type A focused on the use of OnabotulinumoxinA, since this is the brand with the widest range of licensed indications in Italy. Physicians from twenty-four Italian neurorehabilitation units compiled a questionnaire about "real-life" post-stroke spasticity management. OnabotulinumtoxinA was reported to be used in the following average doses: upper limb 316.7 ± 79.1 units; lower limb 327.8 ± 152.3; upper and lower limb 54...
Source: Functional Neurology - July 7, 2017 Category: Neurology Tags: Funct Neurol Source Type: research

Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.
CONCLUSION: Although BTX-A injections improved spasticity, this improvement did not translate to gait outcomes. Addition of physical therapy interventions appeared to improve gait outcomes in this case series. We suggest future randomized control studies to compare effects of physical therapy alone to BTX-A combined with physical therapy on gait outcomes. PMID: 28481738 [PubMed - as supplied by publisher]
Source: Physiotherapy Theory and Practice - May 8, 2017 Category: Physiotherapy Authors: Karakkattil P, Trudelle-Jackson E, Brown HH, Hammontree P, Okolo M Tags: Physiother Theory Pract Source Type: research

Physical therapy for an adult with chronic stroke after botulinum toxin injection for spasticity: a case report.
CONCLUSIONS: This case report demonstrates that physical therapy after BoNTA injections can result in significant functional improvements for individuals with spasticity after chronic stroke that may not be possible with BoNTA injections alone. PMID: 25931655 [PubMed]
Source: Physiotherapy Canada - May 3, 2015 Category: Physiotherapy Authors: Gallagher S, Phadke CP, Ismail F, Boulias C Tags: Physiother Can Source Type: research

Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: Results of the German–Austrian open-label post-marketing surveillance prospective study
Abstract: The current practice in Germany and Austria, and the safety and efficacy of botulinum toxin type A (BoNT-A; Dysport) in the treatment of patients with post-stroke arm spasticity (with no fixed upper-limb contractures), were assessed in this observational prospective non-interventional study. One treatment cycle was documented with assessments at baseline, approximately week 4 (optional), and approximately week 12. Pattern of spasticity, treatment goal, safety and efficacy were recorded. Overall response and goal achievement was rated on a 4-point scale (‘no goal achievement’, ‘goal achievement’, ‘good g...
Source: Journal of the Neurological Sciences - December 23, 2013 Category: Neurology Authors: Wolfgang H. Jost, Harald Hefter, Andrea Reissig, Katja Kollewe, Joerg Wissel Tags: Original Articles Source Type: research

Diagnosis and management of patients with Bell's palsy.
This article discusses potential causes of the condition and identifies the differences between Bell's palsy and stroke. In addition, appropriate strategies for the care of patients with the condition are suggested. Management includes antiviral medication, corticosteroid therapy, eye care, botulinum toxin type A injection, physiotherapy, surgery and acupuncture. Psychological and emotional care of these patients is also important because any facial disability caused by facial nerve paralysis can result in anxiety and stress. PMID: 24299386 [PubMed - in process]
Source: Nursing Standard - December 4, 2013 Category: Nursing Authors: Mooney T Tags: Nurs Stand Source Type: research

Pages: 1  2